Home   >   Resources   >   Posters & Abstracts

Posters

2019

2019
Chuah, E.
AGBT
Platform for report generation and sharing of clinical genomics data.
2019
Dixon, K.
ACMG Annual Meeting
Molecular pathogenesis of familial pancreatic cancer and implications for genetic diagnosis.
2019
Lee, M.
GI ASCO
Comprehensive genomic analysis of metastatic pancreatic adenocarcinoma (mPDAC) reveals a significant proportion of clinical actionable abberations.
2019
Mendis, S.
ASCO
Comprehensive transcriptome analysis reveals link between epigenetic dysregulation, endogenous retrovirus expression and immunogenicity in metastatic colorectal carcinoma.
2019
Moore, R.
AGBT
Integration of whole genome and transcriptome analysis informs personalized therapy decision making and highlights how cancer genomes are shaped by prior therapy.
2019
Pearson, H.
Society of Obstetricians and gynaecologists of Canada Annual Conference
Genomic and transcriptomic immune-tumour profilimg for predictive biomarkers of checkpoint inhibitor response in metastatic cancer.
2019
Roscoe, R.
ICGC ARGO
Management of a large-scale personalized medicine and cancer genomics program.
2019
Roscoe, R.
ICGC ARGO
Early-stage economic evaluation of whole-genome and transcriptome analysis to guide advanced cancer care.
2019
Roscoe, R.
ICGC ARGO
An introduction and illustrative example of matching methods in precision oncology.
2019
Titmuss, E.
Keystone Symposia Conference
Integrated genomic profiling of metastatic tumours to identify biomarkers of response to immune checkpoint inhibitors.
2019
Titmuss, E.
ICGC ARGO
Pan-cancer analysis of advanced patient tumours reveals interaction between therapy and genomic landscapes.
2019
Weinberg, B.A.
ESMO GI
NRG1 fusion-positive gastrointestinal tumours: Afatinib as a novel potential treatment option.
2019
Weymann, D.
ICGC ARGO
An introduction and illustrative example of matching methods in precision oncology.
2019
Weymann, D.
ICGC ARGO
Early-stage economic evaluation of whole-genome and transcriptome analysis to guide advanced cancer care.

2018

2018
Culibrk, L.
BC Cancer Research Centre Research Day
TC-seqR: a statistical framework for estimation of tumour purity and ploidy from whole genome sequencing data.
2018
Culibrk, L.
Genome BC Research Day
TC-seqR: a statistical framework for estimation of tumour purity and ploidy from whole genome sequencing data.
2018
Culibrk, L.
BC Cancer Summit
Ploidetect: interpreteable detection of tumour content and aneuploidy from whole genome sequence data.
2018
Culibrk, L.
BC Cancer Summit
Ploidetect: interpretable detection of tumor content and aneuploidy from whole genome sequence data.
2018
Fan, K.
BC Cancer Summit
Genomic analysis of tumour-immune landscape and determinants of response to immune checkpoint inhibitors in Personalized Oncogenomics patients.
2018
Kwan, H.
BC Cancer Summit
Exploratory analysis of recurrent mutations associated with treatment in metastatic cancers.
2018
Lavoie, J.-M.
BC Cancer Summit
Patient selection for a developmental therapeutics programs using multi-omics.
2018
LeVasseur, N.
ASCO
Whole genome sequencing in metastatic breast cancer - lessons learned from the BC Cancer Agency Personalized OncoGenomics (POG) program.
2018
Liu, L.
ESMO
Clinical benefit of whole genome and transcriptome analysis (WGTA) in metastatic colorectal cancer (MCRC): results from the Personalized OncoGenomics (POG) program.
2018
Liu, L.
BC Cancer Summit
Clinical benefit of whole genome and transcriptome analysis (WGTA) in metastatic colorectal cancer (MCRC): results from the Personalized Oncogenomics program (POG).
2018
Pleasance, E.
BC Cancer Summit
Cancer genome landscapes shaped by prior therapy: the POG500 cohort.
2018
Pleasance, E.
BC Cancer Summit
Integration of whole genome and transcriptome analysis informs personalized therapy decision making and highlights how cancer genomes are shaped by prior therapy.

2017

2017
Bonakdar, M.
CCRC
Comprehensive bioinformatics analysis of whole genome and transcriptome sequence data from individual patient tumours.
2017
Bonakdar, M.
AGBT
Bioinformatics for Personalized OncoGenomics: analysis of whole genome and transcriptome data from individual patient tumours.
2017
Bonakdar, M.
Personalized Medicine Summit
Comprehensive bioinformatics analysis of whole genome and transcriptome sequence data from individual patient tumours.
2017
Chooback, N.
CAMO
Whole genome sequencing (WGS) analysis of lung adenocarcinoma: elucidating the molecular signature.
2017
Jones, M.
AGBT Precision Health
Taking whole genomes to the cancer clinic: integrative analysis for interpretation and communication of whole genome and transcriptome analysis at a tumour board.
2017
Karasinska, J.
Keystone Tumor Metabolism meeting
Prognostic metabolic signature associated with mutant KRAS copy gain in pancreatic ductal adenocarcinoma.
2017
Lim, H.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.
2017
Lim, H.
ASCO
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.
2017
Ma, Y.
AGBT
Bioinformatics for Personalized OncoGenomics: lessons learned from analyzing whole genomes and transcriptomes from 500 patients.
2017
Pearson, H.
4th Canadian Cancer Research Conference
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.
2017
Pearson, H.
CCRC
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.
2017
Pleasance, E.
CCRC
Personalized OncoGenomics: whole genome and transcriptome sequencing informs treatment decisions in the cancer clinic.
2017
Pleasance, E.
Personalized Medicine Summit
Personalized OncoGenomics: whole genome and transcriptome sequencing informs treatment decisions in the cancer clinic.
2017
Roscoe, R.
Society of Research Administrators International (SRAi)
Personalized OncoGenomics (POG) project: program management and process development.
2017
Shen, Y.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics
Clinical application of whole genome and transcriptome sequencing in cancer care.
2017
Thibodeau, M.
CCRC
Whole-genome and whole-transcriptome profiling of a metastatic eccrine porocarcinoma.
2017
Tsang, E.
ASCO
Clinical outcomes after whole genome sequencing in patients with metastatic non small cell lung cancer.
2017
Williamson, L.
CCRC
Genomic profiling of pancreatic ductal adenocarcinoma identifies DNA repair deficient subtype.
2017
Zhao, E.
AACR
Breast cancer whole genomes link homologous recombination deficiency (HRD) with therapeutic outcomes.

2016

2016
Grewal, J.
TFRI- Node
Using machine learning to identify site of origin of metastatic tumours.
2016
Jones, M.
AGBT
Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.
2016
Laskin, J.
AACR
Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care.
2016
Moore, R.
AGBT
Whole genome and transcriptome sequencing for personalized cancer therapy: lessons learned from the first 300 cases.
2016
Schrader, I.
AACR
Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis.
2016
Zhao, E.
CITAC
Guiding platinum-based chemotherapy in breast cancer with a somatic mutation signature of homologous recombination deficiency.

2015

2015
Bose, P.
AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy
Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma.
2015
Fok, A.
Canadian GE3LS and Health Services & Policy Research Conference
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.
2015
Jones, M.
Personalized Medicine Summit
Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.
2015
Koyama, T.
American Society of Human Genetics
Case analysis of advanced cancers with Watson Genomic Analytics.
2015
Lim, H.
ESMO
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.
2015
Ma, Y.
AGBT
A bioinformatics pipeline for analyzing whole genome and transcriptome sequence data from individual patient tumours.
2015
Moore, R.
AGBT
Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.
2015
Rassekh, R.
ASPHO
Pediatric Personalized OncoGenomics (PedsPOG): initial outcomes.
2015
Roscoe, R.
Personalized Medicine Summit
Management of a large -scale personalized medicine project.
2015
Sheffield, B.
USCAP
Personalized OncoGenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.
2015
Sun, S.
AACR
Personalized OncoGenomics in advanced stage breast cancer.
2015
Yip , S.
USCAP
Next generation pathology: the integration of next generation sequencing with glass-based histomorphology and immunohistochemistry.
2015
Zhao, E.
Clinician Investigator Program Research Fellow Day
Searching for targetable mutation signatures in a mixed cancer cohort.
2015
Zhao, E.
Personalized Medicine Summit
Searching for targetable mutation signatures in a mixed cancer cohort.

2014

2014
Jones, M.
7th Annual RECOMB/ISCB Conference on Regulatory & Systems Genomics with DREAM Challenges
Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.
2014
Jones, M.
TFRI- Node
Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.
2014
Kasaian, K.
AACR
Bioinformatic analyses approaches for personalized oncogenomics.
2014
Kasaian, K.
Genome BC SBN
Bioinformatic analyses approaches for personalized oncogenomics.
2014
Laskin, J.
AACR
Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies.
2014
Lim, H.
ESMO
Practical guidance for ethical and policy issues that arise from the clinical application of whole genome sequencing in cancer patients.
2014
Mungall, A.
3rd TCGA Symposium
Using TCGA data to inform on precision medicine in late-stage cancer settings.
2014
Rassekh, R.
TFRI- Node
Pediatric Personalized OncoGenomics (PedsPOG): initial outcomes.
2014
Zhao, E.
Clinician Investigator Trainee Association of Canada Annual General Meeting
Networks, signatures, and personalized medicine: a whole genome approach to cancer therapy.

Abstracts

2019

2019
Csizmok, V.
ICGC ARGO
Personalized OncoGenomics: whole genome and transcriptome sequencing informs treatments decisions in the cancer clinic.
2019
Culibrk, L.
Intelligent Systems for Molecular Biology conference (ISMB)
Ploidetect: interpretable detection of tumor content and aneuploidy from whole genome sequence data.
2019
Karasinska, J.
Keystone Tumor Metabolism Symposium
Metabolic gene expression heterogeneity is associated with survival in pancreatic cancer.
2019
LeVasseur, N.
ASCO
Whole transcriptome sequencing in metastatic cancer – a review of expression outliers in 113 metastatic breast.
2019
Lee, M.
GI ASCO
Comprehensive genomic analysis of metastatic pancreatic ductal adenocarcinoma (mPDAC) reveals a significant proportion of clinical actionable aberrations.
2019
Liu, L.
Society of Gynecologic Oncology
Outcomes of whole genome and transcriptome sequencing (WGTS) in advanced gynecologic malignancies: results from the Personalized OncoGenomics (POG) program.
2019
Nelson, J.
ICGC ARGO
Collaborative publication process in the Personalized OncoGenomics program.
2019
Pender, A.
ESMO
Predictive markers of checkpoint inhibitor activity in adult metastatic solid tumours.
2019
Roscoe, R.
ICGC ARGO
Management of a large-scale project in personalized medicine and cancer genomics.
2019
Thibodeau, M.L.
CCMG/CAGC
Characterization of germline structural variants in moderate-high penetrance hereditary cancer genes in the Personalized OncoGenomics cohort.
2019
Tsang, E.
ASCO
Uncovering clinically relevant gene fusion events with integrated genomic and transcriptomic profiling.
2019
Zhao, E.
ASCO
The whole genome landscape of adult metastatic sarcoma.

2018

2018
Culibrk, L.
ASHG
Ploidetect: interpretable detection of tumour content and aneuploidy from whole genome sequence data.
2018
Lavoie, J.-M.
Cell Symposia: Multi-Omic Studies in Cancer
Patient selection for a developmental therapeutics program using whole genome and transcriptome analysis.
2018
Liu, L.
ASCO
Clinical utility of whole genome sequencing (WGS) in metastatic colorectal cancer (MCRC): results from the Personalized OncoGenomics (POG) program.
2018
Moore, R.
AGBT
Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.
2018
Murchison, S.
CARO
Establishing a role for tumor genomics in radiation medicine: an analysis of head and neck cancer patients enrolled in the Personalized OncoGenomics (POG) initiative.
2018
Thibodeau, M.L.
ASCO
Genomic profiling and mutational signatures associated with the germline deletion polymorphism APOBEC3A_B in diverse cancer types.
2018
Williamson, L.
AACR
Integrated whole genome profiling of the immune tumour interaction identifies predictive biomarkers of checkpoint inhibitor response in metastatic cancer.
2018
Williamson, L.
CARO-COMP-CAMRT
Establishing a role for tumour genomics in radiation medicine: an analysis of primary head and neck cancer data obtained from the Personalized OncoGenomics (POG) initiative.

2017

2017
Tsang, E.
ASCO
Clinical outcomes after whole genome sequencing in patients with metastatic non small cell lung cancer.
2017
Yang, KC.
B.I.G. Research Day at UBC
Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing.
2017
Yang, KC.
MBB Graduate Colloquium
Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing.

2016

2016
Ho, C.
ESMO
The incorporation of tumor whole genome sequencing in practice: the impact on clinical decision-making and therapeutic choices.
2016
Koyama, T.
ASCO
Watson Genomic Analytics efficiently interprets whole genome sequencing data from cancer patients with advanced disease at high throughput.
2016
Laskin, J.
ESMO
Clinicians identify high need to increase their genomic literacy to applied cancer genomics.
2016
Lever, J.
Biocreative conference
CancerMine: a knowledgebase of cancer drivers for personalized cancer treatment.